Shanghai Haixin Group Co Ltd B (900917.SS) stock: key figures, P/E, revenue and dividend

Industrials · Industrial Conglomerates · China · ISIN CNE000000DX2

Price
1.61 USD
Market cap
1.94 bn USD
P/E (2025)
–
P/S (2025)
2.56
Dividend yield
3.06 %
Net margin
23.23 %
Return on equity (ROE)
3.58 %
Return on assets (ROA)
3.01 %

Shanghai Haixin Group Co Ltd B financials

Fiscal year20242025
Revenue795.88 m CNY757.52 m CNY
Gross profit451.78 m CNY448.72 m CNY
Operating income31.08 m CNY45.26 m CNY
EBIT181.51 m CNY207.35 m CNY
Net income150.94 m CNY176.00 m CNY

Full history since 2015, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Shanghai Haixin Group Co Ltd B

Shanghai Haixin Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in China and internationally. It is also involved in leasing of industrial park properties, financial investment and commodity trading, as well as production and sales of chemical drugs through its sales platform or local distributors; and research and development, production, and sales of plush fabrics and clothing. The company also offers property and value-added services. Shanghai Haixin Group Co., Ltd. was founded in 1986 and is headquartered in Shanghai, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.